Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.
Du T, Song Y, Ray A, Wan X, Yao Y, Samur MK, Shen C, Penailillo J, Sewastianik T, Tai YT, Fulciniti M, Munshi NC, Wu H, Carrasco RD, Chauhan D, Anderson KC.
Du T, et al. Among authors: song y.
Blood. 2023 May 25;141(21):2599-2614. doi: 10.1182/blood.2022017897.
Blood. 2023.
PMID: 36630605